nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—HTR6—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.0358	0.0591	CbGpPWpGaD
Raloxifene—HTR2B—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.0327	0.054	CbGpPWpGaD
Raloxifene—HTR6—nervous system—Gilles de la Tourette syndrome	0.032	0.0811	CbGeAlD
Raloxifene—HTR6—central nervous system—Gilles de la Tourette syndrome	0.0308	0.0781	CbGeAlD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0295	0.0487	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.027	0.0445	CbGpPWpGaD
Raloxifene—HTR6—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0252	0.0416	CbGpPWpGaD
Raloxifene—HTR6—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0245	0.0404	CbGpPWpGaD
Raloxifene—HTR6—brain—Gilles de la Tourette syndrome	0.0244	0.062	CbGeAlD
Raloxifene—HTR2B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.023	0.0379	CbGpPWpGaD
Raloxifene—HTR6—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0228	0.0376	CbGpPWpGaD
Raloxifene—ESR2—nervous system—Gilles de la Tourette syndrome	0.0224	0.0569	CbGeAlD
Raloxifene—HTR2B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0223	0.0368	CbGpPWpGaD
Raloxifene—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.0217	0.0359	CbGpPWpGaD
Raloxifene—ESR2—central nervous system—Gilles de la Tourette syndrome	0.0216	0.0548	CbGeAlD
Raloxifene—HTR6—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0212	0.0349	CbGpPWpGaD
Raloxifene—SIGMAR1—midbrain—Gilles de la Tourette syndrome	0.0211	0.0537	CbGeAlD
Raloxifene—HTR2B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0208	0.0343	CbGpPWpGaD
Raloxifene—HTR6—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0206	0.0339	CbGpPWpGaD
Raloxifene—HTR2B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0193	0.0319	CbGpPWpGaD
Raloxifene—HTR6—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0191	0.0316	CbGpPWpGaD
Raloxifene—HTR2B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0188	0.031	CbGpPWpGaD
Raloxifene—CYP19A1—nervous system—Gilles de la Tourette syndrome	0.0177	0.0449	CbGeAlD
Raloxifene—HTR2B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0175	0.0288	CbGpPWpGaD
Raloxifene—HTR2B—nervous system—Gilles de la Tourette syndrome	0.0173	0.044	CbGeAlD
Raloxifene—ESR2—brain—Gilles de la Tourette syndrome	0.0172	0.0435	CbGeAlD
Raloxifene—CYP19A1—central nervous system—Gilles de la Tourette syndrome	0.017	0.0432	CbGeAlD
Raloxifene—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.0167	0.0424	CbGeAlD
Raloxifene—AOX1—brain—Gilles de la Tourette syndrome	0.0165	0.0419	CbGeAlD
Raloxifene—HTR6—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.016	0.0263	CbGpPWpGaD
Raloxifene—ESR1—nervous system—Gilles de la Tourette syndrome	0.0154	0.039	CbGeAlD
Raloxifene—ESR1—central nervous system—Gilles de la Tourette syndrome	0.0148	0.0375	CbGeAlD
Raloxifene—HTR2B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0146	0.024	CbGpPWpGaD
Raloxifene—CYP19A1—brain—Gilles de la Tourette syndrome	0.0135	0.0343	CbGeAlD
Raloxifene—HTR6—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0134	0.0221	CbGpPWpGaD
Raloxifene—SIGMAR1—brain—Gilles de la Tourette syndrome	0.0133	0.0337	CbGeAlD
Raloxifene—HTR2B—brain—Gilles de la Tourette syndrome	0.0133	0.0336	CbGeAlD
Raloxifene—HTR2B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0122	0.0202	CbGpPWpGaD
Raloxifene—ESR1—brain—Gilles de la Tourette syndrome	0.0117	0.0298	CbGeAlD
Raloxifene—CYP2B6—nervous system—Gilles de la Tourette syndrome	0.0114	0.0288	CbGeAlD
Raloxifene—CYP2B6—central nervous system—Gilles de la Tourette syndrome	0.0109	0.0277	CbGeAlD
Raloxifene—CYP2C8—brain—Gilles de la Tourette syndrome	0.00968	0.0246	CbGeAlD
Raloxifene—EBP—Metabolism—HDC—Gilles de la Tourette syndrome	0.00901	0.0149	CbGpPWpGaD
Raloxifene—CYP2B6—brain—Gilles de la Tourette syndrome	0.00868	0.022	CbGeAlD
Raloxifene—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00858	0.0218	CbGeAlD
Raloxifene—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.00826	0.0209	CbGeAlD
Raloxifene—ESR2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00694	0.0115	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00499	0.00824	CbGpPWpGaD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00486	0.00802	CbGpPWpGaD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00472	0.00779	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00444	0.00732	CbGpPWpGaD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0044	0.00726	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00431	0.00711	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00416	0.00687	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00404	0.00667	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00401	0.00662	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0038	0.00627	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00377	0.00622	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00369	0.00609	CbGpPWpGaD
Raloxifene—HTR2B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00364	0.006	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00344	0.00567	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00325	0.00537	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00317	0.00523	CbGpPWpGaD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00308	0.00508	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00308	0.00508	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00289	0.00478	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00287	0.00473	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00281	0.00464	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00281	0.00464	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00264	0.00435	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00262	0.00432	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00258	0.00426	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00241	0.00397	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00201	0.00332	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00183	0.00303	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00179	0.00296	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00174	0.00287	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—HDC—Gilles de la Tourette syndrome	0.00166	0.00274	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00164	0.0027	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00163	0.00269	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00162	0.00268	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00159	0.00262	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00158	0.00261	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00149	0.00245	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00148	0.00244	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00147	0.00243	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00144	0.00238	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—HDC—Gilles de la Tourette syndrome	0.0014	0.00232	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00134	0.00222	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00114	0.00187	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00104	0.00171	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00103	0.0017	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000961	0.00159	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000941	0.00155	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000933	0.00154	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000878	0.00145	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00087	0.00144	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000852	0.00141	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000794	0.00131	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000754	0.00124	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000731	0.00121	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00071	0.00117	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000661	0.00109	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000609	0.00101	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000556	0.000917	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000463	0.000764	CbGpPWpGaD
